Literature DB >> 8497394

[Prevention of thrombosis in ambulatory patients].

H Reilmann1, A M Weinberg, E E Förster, B Happe.   

Abstract

In surgical outpatients who required immobilization with a plaster cast because of injury to the lower limb a deep vein thrombosis occurred in 14%. General thromboprophylaxis seems advisable for surgical outpatients and depends on the severity of trauma and thrombosis risk factors. In a study of 97 patients who received a daily subcutaneous injection of heparin fragment calcium throughout their cast period, only one patient with a deep vein thrombosis was seen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8497394

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  5 in total

1.  The incidence of deep vein thrombosis and pulmonary embolism following cast immobilisation and early functional bracing of Tendo Achilles rupture without thromboprophylaxis.

Authors:  G J Heyes; A Tucker; A L R Michael; R G H Wallace
Journal:  Eur J Trauma Emerg Surg       Date:  2014-06-05       Impact factor: 3.693

2.  [Implementing ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity].

Authors:  H J Kock; K P Schmit-Neuerburg; J Hanke; A Terwort; G Rudofsky; H Hirche
Journal:  Unfallchirurgie       Date:  1994-12

Review 3.  Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization.

Authors:  Aniek Ag Zee; Kelly van Lieshout; Maaike van der Heide; Loes Janssen; Heinrich Mj Janzing
Journal:  Cochrane Database Syst Rev       Date:  2017-08-06

4.  Prevention of deep venous thrombosis in ambulatory or discharged orthopaedic patients. Actual management.

Authors:  J Schmidt; M H Hackenbroch
Journal:  Arch Orthop Trauma Surg       Date:  1995       Impact factor: 3.067

5.  Thromboembolism prophylaxis in orthopaedics: an update.

Authors:  Dimitrios A Flevas; Panayiotis D Megaloikonomos; Leonidas Dimopoulos; Evanthia Mitsiokapa; Panayiotis Koulouvaris; Andreas F Mavrogenis
Journal:  EFORT Open Rev       Date:  2018-04-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.